Education
About Us
Working with TipRanks
Follow Us
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
RESEARCH TOOLSreports
CONCORDBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹1,370.05 - ₹2,658.00
Previous CloseN/A
Volume295.44K
Average Volume (3M)8.29K
Market Cap
₹192.28B
Enterprise Value₹192.01B
Total Cash (Recent Filing)₹2.84B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)54.1
Beta0.80
Next Earnings
Sep 03, 2025EPS Estimate
6.15Last Dividend Ex-Date
Jun 21, 2024Dividend Yield0.46%
Share Statistics
EPS (TTM)13.40
Shares Outstanding104,616,200
10 Day Avg. Volume7,063
30 Day Avg. Volume8,289
Financial Highlights & Ratios
PEG Ratio3.71
Price to Book (P/B)10.59
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,850.00Price Target Upside10.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Concord Biotech Ltd. News
CONCORDBIO FAQ
What was Concord Biotech Ltd.’s price range in the past 12 months?
Concord Biotech Ltd. lowest stock price was ₹1370.05 and its highest was ₹2658.00 in the past 12 months.
What is Concord Biotech Ltd.’s market cap?
Concord Biotech Ltd.’s market cap is ₹192.28B.
When is Concord Biotech Ltd.’s upcoming earnings report date?
Concord Biotech Ltd.’s upcoming earnings report date is Sep 03, 2025 which is in 46 days.
How were Concord Biotech Ltd.’s earnings last quarter?
Concord Biotech Ltd. released its earnings results on May 29, 2025. The company reported ₹13.4 earnings per share for the quarter, beating the consensus estimate of ₹10.05 by ₹3.35.
Is Concord Biotech Ltd. overvalued?
According to Wall Street analysts Concord Biotech Ltd.’s price is currently Undervalued.
Does Concord Biotech Ltd. pay dividends?
Concord Biotech Ltd. pays a Notavailable dividend of ₹8.75 which represents an annual dividend yield of 0.46%. See more information on Concord Biotech Ltd. dividends here
What is Concord Biotech Ltd.’s EPS estimate?
Concord Biotech Ltd.’s EPS estimate is 6.15.
How many shares outstanding does Concord Biotech Ltd. have?
Concord Biotech Ltd. has 104,616,200 shares outstanding.
What happened to Concord Biotech Ltd.’s price movement after its last earnings report?
Concord Biotech Ltd. reported an EPS of ₹13.4 in its last earnings report, beating expectations of ₹10.05. Following the earnings report the stock price went up 1.805%.
Which hedge fund is a major shareholder of Concord Biotech Ltd.?
Currently, no hedge funds are holding shares in IN:CONCORDBIO
Company Description
Concord Biotech Ltd.
Concord Biotech Ltd. (CONCORDBIO) is a prominent biopharmaceutical company engaged in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished formulations. Primarily focused on the therapeutic areas of immunosuppressants, oncology, and anti-infectives, Concord Biotech serves a global clientele with a robust portfolio of high-quality, cost-effective products. The company leverages its state-of-the-art manufacturing facilities and extensive R&D capabilities to address complex healthcare needs worldwide.
Technical Analysis
Biocon Limited
―
Blue Jet Healthcare Limited
―
Jubilant Ingrevia Ltd.
―
Piramal Pharma Limited
―
Syngene International Ltd.
―